Growth Opportunity Ellipsys Medical has recently reintroduced the Ellipsys Vascular Access System with anticipated mid-2026 commercial availability, presenting a clear near-term opportunity for sales outreach to dialysis centers, hospital systems, and vascular access clinics seeking innovative, less invasive AV fistula solutions.

Market Readiness With a compact team in the 11-50 employee range and a focus on clinician and health system partnerships, target opportunities include account-based outreach to mid-sized to large health systems that value streamlined workflows and durable access to support patient outcomes.

Clinical Advantage The percutaneous, ultrasound-guided AV fistula solution reduces surgical incisions and vessel manipulation, offering a compelling value proposition for vascular surgeons and interventional radiologists aiming to shorten procedures, lower complication risk, and improve care quality.

Tech Enablement Leverage Ellipsys Medical’s tech stack and cloud capabilities (AWS, PWA, secure web practices) to position the system as modern, scalable, and easily integrated into existing hospital IT and workflow platforms, supporting upsell of related digital and service offerings.

Financial Readiness With multiple funding investments and a revenue range indicating growth potential, pursue opportunities framed around total cost of care reductions, payer alignment, and potential collaboration on pilots or reimbursement pathway support to accelerate adoption.